News

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...
Agomab Therapeutics NV (?Agomab') today announced that interim data from the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule inhibitor ...
The NIMML Institute, ("NIMML"), a 501 (c)(3) nonprofit institute dedicated to the discovery of novel precision medicines for inflammatory and autoimmune diseases, will present results from two novel ...
Single-game tickets are on sale now! Explore all of the exciting matchups and incredible promotions below. Promotions are subject to change or cancellation. Looking to create unforgettable memories ...